Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig

Author： Kato Y. Kita Y. Hirasawa-Taniyama Y. Nishio M. Mihara K. Ito K. Yamanaka T. Seki J. Miyata S. Mutoh S.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.473, Iss.2, 2003-07, pp. : 163-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vorapaxar: a novel protease-activated receptor-1 inhibitor

By Gurbel Paul A Jeong Young-Hoon Tantry Udaya S

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1445-1453

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K Maryanoff Bruce E Zhang Han-Cheng Andrade-Gordon Patricia

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite

In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist

By Kato Y. Kita Y. Nishio M. Hirasawa Y. Ito K. Yamanaka T. Motoyama Y. Seki J.

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 197-202

Elsevier

Access to resources Recommend Favorite

Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes

By Debeir T. Vige X. Benavides J.

European Journal of Pharmacology, Vol. 323, Iss. 1, 1997-03 ,pp. : 111-117

Elsevier

Access to resources Recommend Favorite

Effects of the orally active non-peptide bradykinin B 2 receptor antagonist, FR173657, on plasma extravasation in guinea pig airways

By Watanabe M. Yoshihara S. Abe T. Oyama M. Arisaka O.

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 373-378

Elsevier

Access to resources Recommend Favorite